-
Je něco špatně v tomto záznamu ?
Cognitive and Behavioral Development of 9-Year-Old Children After Maternal Cancer During Pregnancy: A Prospective Multicenter Cohort Study
IA. Van Assche, EA. Huis In 't Veld, K. Van Calsteren, M. van Gerwen, J. Blommaert, E. Cardonick, MJ. Halaska, R. Fruscio, M. Fumagalli, J. Lemiere, EM. van Dijk-Lokkart, C. Fontana, H. van Tinteren, J. De Ridder, M. van Grotel, MM. van den...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu multicentrická studie, časopisecké články, práce podpořená grantem
Odkazy
PubMed
36634293
DOI
10.1200/jco.22.02005
Knihovny.cz E-zdroje
- MeSH
- dítě MeSH
- kognice MeSH
- kohortové studie MeSH
- lidé MeSH
- nádory * farmakoterapie MeSH
- novorozenec MeSH
- předčasný porod * MeSH
- prospektivní studie MeSH
- těhotenství MeSH
- zpožděný efekt prenatální expozice * MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- novorozenec MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.This multicenter cohort study reports on the long-term effects of prenatal exposure to maternal cancer and its treatment on cognitive and behavioral outcomes in 9-year-old children. In total, 151 children (mean age, 9.3 years; range, 7.8-10.6 years) were assessed using a neurocognitive test battery and parent-report behavioral questionnaires. During pregnancy, 109 children (72.2%) were exposed to chemotherapy (only or in combination with other treatment modalities), 18 (11.9%) to surgery only, 16 (10.6%) to radiotherapy, one to trastuzumab, and 16 (10.6%) were not exposed to oncologic treatment. Mean cognitive and behavioral outcomes were within normal ranges. Gestational age at birth showed a positive association with Full Scale Intelligence Quotient (FSIQ), with the average FSIQ score increasing by 1.6 points for each week increase in gestational age (95% CI, 0.7 to 2.5; P < .001). No difference in FSIQ was found between treatment types (F[4,140] = 0.45, P = .776). In children prenatally exposed to chemotherapy, no associations were found between FSIQ and chemotherapeutic agent, exposure level, or timing during pregnancy. These results indicate a reassuring follow-up during the critical maturational period of late childhood, when complex functions develop and rely on the integrity of early brain development. However, associations were observed with preterm birth, maternal death, and maternal education.
Amsterdam Reproduction and Development Child Development Amsterdam the Netherlands
Center for Gynecological Oncology Netherlands Cancer Institute Amsterdam the Netherlands
Department of Clinical Sciences and Community Health University of Milan Milano Italy
Department of Development and Regeneration Unit of Woman and Child KU Leuven Belgium
Department of Obstetrics and Gynecology Cooper University Health Care Camden NJ
Department of Oncology Laboratory of Experimental Radiotherapy KU Leuven Belgium
Department of Oncology Unit of Gynaecological Oncology KU Leuven Belgium
Department of Oncology Unit of Pediatric Oncology KU Leuven Belgium
Division of Foetomaternal Medicine Department of Obstetrics and Gynaecology UZ Leuven Belgium
Division of Gynaecological Oncology Department of Obstetrics and Gynaecology UZ Leuven Belgium
Division of Pediatric Hemato Oncology Department of Pediatrics UZ Leuven Belgium
Division of Pediatric Neurology Department of Pediatrics UZ Leuven Belgium
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico NICU Milano Italy
Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003840
- 003
- CZ-PrNML
- 005
- 20230425140920.0
- 007
- ta
- 008
- 230418s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1200/JCO.22.02005 $2 doi
- 035 __
- $a (PubMed)36634293
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Van Assche, Indra A $u Department of Development and Regeneration, Unit of Woman and Child, KU Leuven, Belgium $1 https://orcid.org/0000000312054914
- 245 10
- $a Cognitive and Behavioral Development of 9-Year-Old Children After Maternal Cancer During Pregnancy: A Prospective Multicenter Cohort Study / $c IA. Van Assche, EA. Huis In 't Veld, K. Van Calsteren, M. van Gerwen, J. Blommaert, E. Cardonick, MJ. Halaska, R. Fruscio, M. Fumagalli, J. Lemiere, EM. van Dijk-Lokkart, C. Fontana, H. van Tinteren, J. De Ridder, M. van Grotel, MM. van den Heuvel-Eibrink, L. Lagae, F. Amant
- 520 9_
- $a Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.This multicenter cohort study reports on the long-term effects of prenatal exposure to maternal cancer and its treatment on cognitive and behavioral outcomes in 9-year-old children. In total, 151 children (mean age, 9.3 years; range, 7.8-10.6 years) were assessed using a neurocognitive test battery and parent-report behavioral questionnaires. During pregnancy, 109 children (72.2%) were exposed to chemotherapy (only or in combination with other treatment modalities), 18 (11.9%) to surgery only, 16 (10.6%) to radiotherapy, one to trastuzumab, and 16 (10.6%) were not exposed to oncologic treatment. Mean cognitive and behavioral outcomes were within normal ranges. Gestational age at birth showed a positive association with Full Scale Intelligence Quotient (FSIQ), with the average FSIQ score increasing by 1.6 points for each week increase in gestational age (95% CI, 0.7 to 2.5; P < .001). No difference in FSIQ was found between treatment types (F[4,140] = 0.45, P = .776). In children prenatally exposed to chemotherapy, no associations were found between FSIQ and chemotherapeutic agent, exposure level, or timing during pregnancy. These results indicate a reassuring follow-up during the critical maturational period of late childhood, when complex functions develop and rely on the integrity of early brain development. However, associations were observed with preterm birth, maternal death, and maternal education.
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a prospektivní studie $7 D011446
- 650 12
- $a zpožděný efekt prenatální expozice $7 D011297
- 650 12
- $a předčasný porod $7 D047928
- 650 12
- $a nádory $x farmakoterapie $7 D009369
- 650 _2
- $a kognice $7 D003071
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Huis In 't Veld, Evangeline A $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands $u Center for Gynecological Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands
- 700 1_
- $a Van Calsteren, Kristel $u Department of Development and Regeneration, Unit of Woman and Child, KU Leuven, Belgium $u Division of Foetomaternal Medicine, Department of Obstetrics and Gynaecology, UZ Leuven, Belgium $1 https://orcid.org/0000000224386783
- 700 1_
- $a van Gerwen, Mathilde $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands $u Center for Gynecological Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands $u Department of Child and Adolescent Psychiatry and Psychosocial Care, Amsterdam UMC, University of Amsterdam, the Netherlands
- 700 1_
- $a Blommaert, Jeroen $u Department of Oncology, Unit of Pediatric Oncology, KU Leuven, Belgium $u Department of Oncology, Unit of Gynaecological Oncology, KU Leuven, Belgium $u Department of Oncology, Laboratory of Experimental Radiotherapy, KU Leuven, Belgium $1 https://orcid.org/0000000247469688
- 700 1_
- $a Cardonick, Elyce $u Department of Obstetrics and Gynecology, Cooper University Health Care, Camden, NJ $1 https://orcid.org/0000000322033367
- 700 1_
- $a Halaska, Michael J $u Department of Obstetric Gynecology, University Hospital Kralovske Vinohrady and 3rd Medical Faculty, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000160552569 $7 xx0062494
- 700 1_
- $a Fruscio, Robert $u Department of Medicine and Surgery, Clinic of Obstetrics and Gynecology, University of Milan-Bicocca, San Gerardo Hospital, Monza, Italy $1 https://orcid.org/0000000156882194
- 700 1_
- $a Fumagalli, Monica $u Department of Clinical Sciences and Community Health, University of Milan, Milano, Italy $u Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, NICU, Milano, Italy
- 700 1_
- $a Lemiere, Jurgen $u Department of Oncology, Unit of Pediatric Oncology, KU Leuven, Belgium $u Division of Pediatric Hemato-Oncology, Department of Pediatrics, UZ Leuven, Belgium $1 https://orcid.org/0000000215750889
- 700 1_
- $a van Dijk-Lokkart, Elisabeth M $u Department of Child and Adolescent Psychiatry and Psychosocial Care, Amsterdam UMC, University of Amsterdam, the Netherlands $u Amsterdam Reproduction and Development, Child Development, Amsterdam, the Netherlands
- 700 1_
- $a Fontana, Camilla $u Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, NICU, Milano, Italy $1 https://orcid.org/0000000282177824
- 700 1_
- $a van Tinteren, Harm $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
- 700 1_
- $a De Ridder, Jessie $u Division of Pediatric Neurology, Department of Pediatrics, UZ Leuven, Belgium $u Department of Development and Regeneration, Unit Locomotor and Neurological Disorders, KU Leuven, Belgium $1 https://orcid.org/0000000285557822
- 700 1_
- $a van Grotel, Martine $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
- 700 1_
- $a van den Heuvel-Eibrink, Marry M $u Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands $u UMCU-Wilhelmina Children's Hospital, Utrecht, the Netherlands
- 700 1_
- $a Lagae, Lieven $u Department of Development and Regeneration, Unit of Woman and Child, KU Leuven, Belgium $u Division of Pediatric Neurology, Department of Pediatrics, UZ Leuven, Belgium
- 700 1_
- $a Amant, Frédéric $u Center for Gynecological Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands $u Department of Oncology, Unit of Gynaecological Oncology, KU Leuven, Belgium $u Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, UZ Leuven, Belgium $1 https://orcid.org/0000000254524905
- 773 0_
- $w MED00002596 $t Journal of clinical oncology : official journal of the American Society of Clinical Oncology $x 1527-7755 $g Roč. 41, č. 8 (2023), s. 1527-1532
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36634293 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425140916 $b ABA008
- 999 __
- $a ok $b bmc $g 1924485 $s 1190049
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 41 $c 8 $d 1527-1532 $e 20230112 $i 1527-7755 $m Journal of clinical oncology $n J. clin. Oncol. $x MED00002596
- LZP __
- $a Pubmed-20230418